Dihomo-γ-linolenic acid inhibits tumour necrosis factor-α production by human leucocytes independently of cyclooxygenase activity

Immunology

Volumn 110, Issue 3, 2003, Pages 348-357

  Dooper, Maaike M B W ^a   Van Riel, Boet ^a   Graus, Yvo M F ^a   M'Rabet, Laura ^a  

^a NUMICO RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BORAGE OIL; CYTOKINE; DIHOMO GAMMA LINOLENIC ACID; EDIBLE OIL; FATTY ACID; ICOSANOID; INDOMETACIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID METABOLISM; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; KINETICS; MONONUCLEAR CELL; PRIORITY JOURNAL;

8,11,14-EICOSATRIENOIC ACID; CELLS, CULTURED; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242636589     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01749.x     Document Type: Article

References (53)

1. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br J Nutr 2002; 87:S31-48.
2. Calder PC. Dietary fatty acids and the immune system. Lipids 1999; 34 (Suppl. ):S137-40.
3. Endres S. n-3 polyunsaturated fatty acids and human cytokine synthesis. Lipids 1996; 31 (Suppl. ):S239-42.
4. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993; 119:867-73.
5. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br J Rheumatol 1994; 33:847-52.
6. Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM, Laposata M. gamma-Linolenic acid treatment of rheumatoid arthritis: a randomized, placebo-controlled trial. Arthritis Rheum 1996; 39:1808-17.
7. Cleland LG, French JK, Betts WH, Murphy GA, Elliott MJ. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988; 15:1471-5.
8. Kjeldsen-Kragh J, Lund JA, Riise T, Finnanger B, Haaland K, Finstad R, Mikkelsen K, Forre O. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J Rheumatol 1992; 19:1531-6.
9. van der Tempel H, Tulleken JE, Limburg PC, Muskiet FA, van Rijswijk MH. Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990; 49:76-80.
10. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990; 33:810-20.
11. Endres S, Ghorbani R, Kelley VE et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-71.
12. Endres S, Meydani SN, Dinarello CA. Effects of omega 3 fatty acid supplements on ex vivo synthesis of cytokines in human volunteers: comparison with oral aspirin and ibuprofen. World Rev Nutr Diet 1991; 66:401-6.
13. DeLuca P, Rossetti RG, Alavian C, Karim P, Zurier RB. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J Invest Med 1999; 47: 246-50.
14. Furse RK, Rossetti RG, Zurier RB. Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes. J Immunol 2001; 167:490-6.
15. Robinson DR, Tateno S, Patel B, Hirai A. Lipid mediators of inflammatory and immune reactions. JPEN J Parenter Enteral Nutr 1988; 12:37S-42S.
16. Zhou L, Nilsson A. Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res 2001; 42:1521-42.
17. Seeds MC, Bass DA. Regulation and metabolism of arachidonic acid. Clin Rev Allergy Immunol 1999; 17:5-26.
18. Pullman-Mooar S, Laposata M, Lem D, Holman RT, Leventhal LJ, DeMarco D, Zurier RB. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gammalinolenic acid. Arthritis Rheum 1990; 33:1526-33.
19. Kumar GS, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids 1994; 50:331-4.
20. Caughey GE, Pouliot M, Cleland LG, James MJ. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol 1997; 158:351-8.
21. Dooper MM, Wassink L, M'Rabet L, Graus YM. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 2002; 107:152-9.
22. Bligh ED, Dyer WJ. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7.
23. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997; 41:203-34.
24. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990; 6:24-44 [discussion 59-62].
25. Galella G, Marangoni F, Rise P, Colombo C, Galli G, Galli C. n-6 and n-3 fatty acid accumulation in thp-1 cell phospholipids. Biochim Biophys Acta 1993; 1169:280-90.
26. Baldie G, Kaimakamis D, Rotondo D. Fatty acid modulation of cytokine release from human monocytic cells. Biochim Biophys Acta 1993; 1179:125-33.
27. Calder PC, Bond JA, Harvey DJ, Gordon S, Newsholme EA. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 1990; 269:807-14.
28. Joulain C, Guichardant M, Lagarde M, Prigent AF. Influence of polyunsaturated fatty acids on lipid metabolism in human blood mononuclear cells and early biochemical events associated with lymphocyte activation. J Lipid Med Cell Signal 1995; 11:63-79.
29. Karsten S, Schafer G, Schauder P. Cytokine production and DNA synthesis by human peripheral lymphocytes in response to palmitic, stearic, oleic, and linoleic acid. J Cell Physiol 1994; 161:15-22.
30. Ferrante JV, Huang ZH, Nandoskar M et al. Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid: inhibition of tumor necrosis factor production. J Clin Invest 1997; 99:1445-52.
31. Calder PC, Yaqoob P, Harvey DJ, Watts A, Newsholme EA. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 1994: 300:509-18.
32. Khalfoun B, Thibault G, Lacord M, Gruel Y, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. Scand J Immunol 1996; 43:248-56.
33. Purasiri P, McKechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 1997; 92:166-72.
34. Jenski LJ, Scherer JM, Caldwell LD, Ney VA, Stillwell W. The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro. Lipids 1998; 33:869-78.
35. Soyland E. Nenseter MS, Braathen L, Drevon CA. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro. Eur J Clin Invest 1993; 23:112-21.
36. Calder PC, Newsholme EA. Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci (Colch) 1992; 82:695-700.
37. Calder PC, Bond JA, Bevan SJ, Hunt SV, Newsholme EA. Effect of fatty acids on the proliferation of concanavalin A-stimulated rat lymph node lymphocytes. Int J Biochem 1991; 23:579-88.
38. Santoli D, Zurier RB. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism. J Immunol 1989; 143:1303-9.
39. DeMarco DM, Santoli D, Zurier RB. Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes. J Leukoc Biol 1994; 56:612-5.
40. Zurier RB, Rossetti RG, Seiler CM, Laposata M. Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 1999; 60:371-5.
41. Borofsky MA, Zurier RB, Rosenbaum H, Weiner DB, Williams WV. Effects of polyunsaturated fatty acids on interleukin-2-dependent T cell growth. Immunol Res 1992; 11:154-64.
42. Iversen L, Fogh K, Kragballe K. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res 1992; 284: 222-6.
43. Miller CC, McCreedy CA, Jones AD, Ziboh VA. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products. Prostaglandins 1988; 35:917-38.
44. Rola-Pleszczynski M, Chavaillaz PA, Lemaire I. Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukot Med 1986; 23:207-10.
45. Gagnon L, Filion LG, Dubois C, Rola-Pleszczynski M. Leukotrienes and macrophage activation, augmented cytotoxic activity and enhanced interleukin-1, tumor necrosis factor and hydrogen peroxide production. Agents Actions 1989; 26: 141-7.
46. Goldyne ME. Leukotrienes: clinical significance. J Am Acad Dermatol 1984; 10:659-68.
47. Johnson HM, Torres BA. Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol 1984; 132:413-6.
48. + lymphocyte phenotype and immunoregulatory functions. J Immunol 1985; 135:1357-60.
49. Payan DG, Missirian-Bastian A, Goetzl EJ. Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc Natl Acad Sci USA 1984; 81:3501-5.
50. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999; 19:63-90.
51. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993; 151:6853-61.
52. Kelley DS, Taylor PC, Nelson GJ et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999; 34:317-24.
53. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121:547-55.